BOSTON, Feb. 12, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL ...

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials ® platform with advanced analytics ...

Parexel is shedding its medical imaging and informatics biz as the reborn Calyx goes it alone (although still under the Pamplona Capital umbrella). The move is designed to “simplify and streamline ...

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched next generation risk-based monitoring capabilities, expanding its Perceptive ...

Perceptive Informatics Inc., a subsidiary of Waltham-based contract research organization Parexel International Corp. (Nasdaq: PRXL), has named the former CEO of Clinical Solutions as president to ...

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new ...

BOSTON & DURHAM, N.C.--(BUSINESS WIRE)--Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical ...

In a recent press release from Microsoft Corp. and PAREXEL International Corp., a leading global biopharmaceutical services organization, on Tuesday announced a technology development alliance aimed ...

Global biopharmaceutical services organization, PAREXEL International Corporation ( PRXL) launched a new version of its industry standard ClinPhone RTSM (Randomization and Trial Supply Management) ...

BOSTON, Oct. 3, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL)(" PAREXEL" or the "Company"), a global clinical research organization, announced today that the Company has ...